Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad

This cross-sectional study investigated nonconventional therapies for COVID-19 in Trinidad, emphasizing the need for documentation supporting future pharmaceutical research. The survey, conducted from June 20 to July 19, 2022, garnered responses from 57 participants aged 18 and above, with 82.46% va...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Sani Ismaila, Kavita Ranjeeta Lall, Kezia Sookram, Venkatesan Sundaram, Kegan Romelle Jones
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Scientifica
Online Access:http://dx.doi.org/10.1155/sci5/1545153
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850065742189297664
author Mohammad Sani Ismaila
Kavita Ranjeeta Lall
Kezia Sookram
Venkatesan Sundaram
Kegan Romelle Jones
author_facet Mohammad Sani Ismaila
Kavita Ranjeeta Lall
Kezia Sookram
Venkatesan Sundaram
Kegan Romelle Jones
author_sort Mohammad Sani Ismaila
collection DOAJ
description This cross-sectional study investigated nonconventional therapies for COVID-19 in Trinidad, emphasizing the need for documentation supporting future pharmaceutical research. The survey, conducted from June 20 to July 19, 2022, garnered responses from 57 participants aged 18 and above, with 82.46% vaccinated. The majority (81%) utilized both conventional and nonconventional therapies, revealing insights for potential alternatives to traditional treatments. Conventional treatments, including antibiotics, Ivermectin, anti-inflammatories, analgesics, bronchodilators, and cough/flu syrups, were frequently reported. Nonconventional therapies encompassed vitamins, minerals, supplements, and various plant and animal products. When participants used conventional therapies, either alone or in combination with nonconventional ones, 13.21% reported side effects. These included severe thirst, headache, nausea, drowsiness, and one case of weight gain. Conversely, those exclusively using nonconventional treatments reported no side effects. Encouragingly, nonconventional therapies demonstrated promising effects in managing COVID-19, emphasizing the need for meticulous selection, research, and development of their bioactive compounds as potential alternatives to conventional therapies.
format Article
id doaj-art-7816efe90d9c4a1c818796ec04fbaa90
institution DOAJ
issn 2090-908X
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Scientifica
spelling doaj-art-7816efe90d9c4a1c818796ec04fbaa902025-08-20T02:48:55ZengWileyScientifica2090-908X2024-01-01202410.1155/sci5/1545153Conventional and Nonconventional Therapies for COVID-19 Management in TrinidadMohammad Sani Ismaila0Kavita Ranjeeta Lall1Kezia Sookram2Venkatesan Sundaram3Kegan Romelle Jones4Department of Basic Veterinary SciencesDepartment of Basic Veterinary SciencesDepartment of Basic Veterinary SciencesDepartment of Basic Veterinary SciencesDepartment of Basic Veterinary SciencesThis cross-sectional study investigated nonconventional therapies for COVID-19 in Trinidad, emphasizing the need for documentation supporting future pharmaceutical research. The survey, conducted from June 20 to July 19, 2022, garnered responses from 57 participants aged 18 and above, with 82.46% vaccinated. The majority (81%) utilized both conventional and nonconventional therapies, revealing insights for potential alternatives to traditional treatments. Conventional treatments, including antibiotics, Ivermectin, anti-inflammatories, analgesics, bronchodilators, and cough/flu syrups, were frequently reported. Nonconventional therapies encompassed vitamins, minerals, supplements, and various plant and animal products. When participants used conventional therapies, either alone or in combination with nonconventional ones, 13.21% reported side effects. These included severe thirst, headache, nausea, drowsiness, and one case of weight gain. Conversely, those exclusively using nonconventional treatments reported no side effects. Encouragingly, nonconventional therapies demonstrated promising effects in managing COVID-19, emphasizing the need for meticulous selection, research, and development of their bioactive compounds as potential alternatives to conventional therapies.http://dx.doi.org/10.1155/sci5/1545153
spellingShingle Mohammad Sani Ismaila
Kavita Ranjeeta Lall
Kezia Sookram
Venkatesan Sundaram
Kegan Romelle Jones
Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad
Scientifica
title Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad
title_full Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad
title_fullStr Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad
title_full_unstemmed Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad
title_short Conventional and Nonconventional Therapies for COVID-19 Management in Trinidad
title_sort conventional and nonconventional therapies for covid 19 management in trinidad
url http://dx.doi.org/10.1155/sci5/1545153
work_keys_str_mv AT mohammadsaniismaila conventionalandnonconventionaltherapiesforcovid19managementintrinidad
AT kavitaranjeetalall conventionalandnonconventionaltherapiesforcovid19managementintrinidad
AT keziasookram conventionalandnonconventionaltherapiesforcovid19managementintrinidad
AT venkatesansundaram conventionalandnonconventionaltherapiesforcovid19managementintrinidad
AT keganromellejones conventionalandnonconventionaltherapiesforcovid19managementintrinidad